Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Vectors for cancer gene therapy

J Zhang1, S J Russell

  • 1Cambridge Centre for Protein Engineering, MRC Centre, UK.

Cancer Metastasis Reviews
|September 1, 1996
PubMed
Summary

This review explores viral and non-viral vector systems for cancer gene therapy, detailing their pros and cons across six distinct strategies. It highlights areas for vector development and the potential of replicating viruses for treating disseminated cancers.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

In vivo clonotypic regulation of human myelin basic protein-reactive T cells by T cell vaccination.

Journal of immunology (Baltimore, Md. : 1950)·1995
Same author

Superantigen reactivity of gamma delta T cell clones isolated from patients with multiple sclerosis and controls.

Cellular immunology·1995
Same author

Tissue distribution of cocaine methyl esterase and ethyl transferase activities: correlation with carboxylesterase protein.

The Journal of pharmacology and experimental therapeutics·1995
Same author

Suppression of insulitis in non-obese diabetic (NOD) mice by oral insulin administration is associated with selective expression of interleukin-4 and -10, transforming growth factor-beta, and prostaglandin-E.

The American journal of pathology·1995
Same author

Molecular cloning and characterization of NF-IL3A, a transcriptional activator of the human interleukin-3 promoter.

Molecular and cellular biology·1995
Same author

A potential vulnerability locus for schizophrenia on chromosome 6p24-22: evidence for genetic heterogeneity.

Nature genetics·1995

Area of Science:

  • Oncology
  • Gene Therapy
  • Virology

Background:

  • Numerous viral and non-viral vector systems are available for gene therapy.
  • Cancer gene therapy encompasses diverse strategies, each with specific vector requirements.

Purpose of the Study:

  • To critically evaluate the advantages and disadvantages of various vector systems for distinct cancer gene therapy approaches.
  • To identify areas in vector biology requiring further advancement for improved efficacy.
  • To explore the potential of replicating viruses for in vivo gene delivery in disseminated cancers.

Main Methods:

  • Review and discussion of existing literature on viral and non-viral vector systems.
  • Analysis of vector suitability for six major cancer gene therapy protocols.
  • Examination of vector biology aspects needing further development.

Main Results:

  • Gene therapy protocols for cancer include cell-based vaccines, in situ tumor vaccination, anti-angiogenesis, T-lymphocyte enhancement, hematopoietic stem cell modification, and direct tumor cell killing.
  • Each strategy imposes unique demands on vector systems, influencing vector selection and development.
  • Replicating viruses show promise for efficient in vivo gene transfer to widespread cancers.

Conclusions:

  • The choice of vector system is critical and strategy-dependent in cancer gene therapy.
  • Further research into vector biology is essential to optimize gene delivery for various cancer treatment modalities.
  • Replicating viruses represent a promising avenue for treating disseminated cancers through gene therapy.

Related Experiment Videos